One shot instead of many? a cholesterol drug puts simplicity to the test
NCT ID NCT06837077
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This trial investigates whether a single injection of the experimental drug SHR-1209 can replace multiple injections for lowering cholesterol. Healthy volunteers aged 18 to 55 will receive both single-site and multiple-site injections in a crossover design to compare pain, safety, and how the drug moves through the body. The goal is to see if a simpler injection method could make long-term cholesterol control easier for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental injectable drug called SHR-1209
- What this could lead to
- If successful, this could simplify cholesterol treatment to a single injection per dose, improving convenience and long-term disease control.
- What could go wrong
- This is an early-phase trial in healthy volunteers, not patients, so results may not translate directly to real-world use. The drug may still cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of USTC
Hefei, Anhui, 230000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.